← Back to Clinical Trials
Recruiting NCT04304846

NCT04304846 AttachMent Preterm in the Loire Infant Follow-up Team

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04304846
Status Recruiting
Phase
Sponsor University Hospital, Angers
Condition Preterm Birth
Study Type OBSERVATIONAL
Enrollment 90 participants
Start Date 2021-01-07
Primary Completion 2025-01-06

Eligibility & Interventions

Sex All sexes
Min Age 3 Years
Max Age 6 Years
Study Type OBSERVATIONAL
Interventions
Questionnaires and interviews

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 90 participants in total. It began in 2021-01-07 with a primary completion date of 2025-01-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to describe the attachment representations of children born prematurely at age 3 and 5 with regard to their neurocognitive and behavioral development.

Eligibility Criteria

Inclusion Criteria: * Children born in the neonatal reanimation department of Angers and Nantes University Hospitals * Extrem preterm infants (term of birth less than or equal to 28 weeks of amenorrhea) * Children included in the regional monitoring network for vulnerable newborns (Réseau Grandir Ensemble en Pays de la Loire, RGE) * Children with a follow-up consultation at age 3 scheduled as part of the classic RGE follow-up on the Angers and Nantes University Hospitals * Informed consent dated and signed by the parents or the holder of the parental authority * Affiliated to a Social Security scheme Exclusion Criteria: * Child with severe neurocognitive impairment or severe autism trait-type behavioral disorder in the 2-year RGE follow-up evaluation

Contact & Investigator

Central Contact

Denise Jolivot, MD

✉ DeJolivot@chu-angers.fr

📞 33-2-41-35-58-08

Principal Investigator

Elise Riquin, MD

PRINCIPAL INVESTIGATOR

University Hospital of Angers

Frequently Asked Questions

Who can join the NCT04304846 clinical trial?

This trial is open to participants of all sexes, aged 3 Years or older, up to 6 Years, studying Preterm Birth. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04304846 currently recruiting?

Yes, NCT04304846 is actively recruiting participants. Contact the research team at DeJolivot@chu-angers.fr for enrollment information.

Where is the NCT04304846 trial being conducted?

This trial is being conducted at Angers, France, Nantes, France.

Who is sponsoring the NCT04304846 clinical trial?

NCT04304846 is sponsored by University Hospital, Angers. The principal investigator is Elise Riquin, MD at University Hospital of Angers. The trial plans to enroll 90 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology